| Literature DB >> 32327985 |
Daniela Cortese1, Francesco Riganello1,2, Francesco Arcuri1, Lucia Lucca1, Paolo Tonin1, Caroline Schnakers3,4, Steven Laureys2.
Abstract
The assessment of the consciousness level of Unresponsive Wakefulness Syndrome (UWS) patients often depends on a subjective interpretation of the observed spontaneous and volitional behavior. To date, the misdiagnosis level is around 30%. The aim of this study was to observe the behavior of UWS patients, during the administration of noxious stimulation by a Trace Conditioning protocol, assessed by the Galvanic Skin Response (GSR) and Heart Rate Variability (HRV) entropy. We recruited 13 Healthy Control (HC) and 30 UWS patients at 31 ± 9 days from the acute event evaluated by Coma Recovery Scale-Revised (CRS-R) and Nociception Coma Scale (NCS). Two different stimuli [musical stimulus (MUS) and nociceptive stimulus (NOC)], preceded, respectively by two different tones, were administered following the sequences (A) MUS1 - NOC1 - MUS2 - MUS3 - NOC2 - MUS4 - NOC3 - NOC*, and (B) MUS1*, NOC1*, NOC2*, MUS2*, NOC3*, MUS3*, NOC4*, MUS4*. All the (*) indicate the only tones administration. CRS-R and NCS assessments were repeated for three consecutive weeks. MUS4, NOC3, and NOC* were compared for GSR wave peak magnitude, time to reach the peak, and time of wave's decay by Wilcoxon's test to assess the Conditioned Response (CR). The Sample Entropy (SampEn) was recorded in baseline and both sequences. Machine Learning approach was used to identify a rule to discriminate the CR. The GSR magnitude of CR was higher comparing music stimulus (p < 0.0001) and CR extinction (p < 0.002) in nine patients and in HC. Patients with CR showed a higher SampEn in sequence A compared to patients without CR. Within the third and fourth weeks from protocol administration, eight of the nine patients (88.9%) evolved into MCS. The Machine-learning showed a high performance to differentiate presence/absence of CR (≥95%). The possibility to observe the CR to the noxious stimulus, by means of the GSR and SampEn, can represent a potential method to reduce the misdiagnosis in UWS patients.Entities:
Keywords: Galvanic Skin Response (GSR); HRV (heart rate variability); conditional learning; disorders of consciousness; entropy; pain; trace conditioning; unresponsive wakefulness syndrome
Year: 2020 PMID: 32327985 PMCID: PMC7161674 DOI: 10.3389/fnhum.2020.00097
Source DB: PubMed Journal: Front Hum Neurosci ISSN: 1662-5161 Impact factor: 3.169
Demographic information of groups, test results and CRS-R/NCS assessments of UWS patients.
| 1 | UWS | |||||||||
| 2 | ||||||||||
| 3 | ||||||||||
| 4 | ||||||||||
| 5 | ||||||||||
| 6 | ||||||||||
| 7 | ||||||||||
| 8 | ||||||||||
| 9 | ||||||||||
| 10 | 66–70 | HEM | 23 | 0 | 4/4 | 7/3 | 4/3 | 7/5 | UWS | |
| 11 | 40–45 | HEM | 55 | 0 | 4/1 | 4/1 | 4/1 | 4/1 | UWS | |
| 12 | 46–50 | HEM | 32 | 0 | 4/1 | 3/4 | 3/3 | 5/4 | UWS | |
| 13 | 56–60 | HEM | 24 | 0 | 5/3 | 4/3 | 5/3 | 5/3 | UWS | |
| 14 | 56–60 | HEM | 35 | 0 | 4/3 | 4/3 | 4/3 | 6/3 | UWS* | |
| 15 | 56–60 | HEM | 39 | 0 | 3/1 | 5/3 | 5/3 | 6/3 | UWS | |
| 16 | 66–70 | HEM | 58 | 0 | 5/3 | 5/3 | 6/3 | 6/3 | UWS | |
| 17 | 60–65 | HEM | 34 | 0 | 5/3 | 6/3 | 5/3 | 4/4 | UWS | |
| 18 | 56–60 | TBI | 30 | 0 | 5/1 | 5/4 | 4/3 | 5/4 | UWS | |
| 19 | 46–50 | TBI | 23 | 0 | 2/1 | 7/5 | 5/3 | 5/5 | UWS | |
| 20 | 60–65 | TBI | 33 | 0 | 6/3 | 6/3 | 6/3 | 6/3 | UWS | |
| 21 | 56–60 | TBI | 36 | 0 | 5/2 | 5/2 | 5/2 | 7/5 | UWS | |
| 22 | 20–25 | TBI | 27 | 0 | 5/2 | 6/2 | 6/4 | 6/4 | UWS | |
| 23 | 20–25 | TBI | 27 | 0 | 4/3 | 6/4 | 6/3 | 5/3 | UWS | |
| 24 | 26–30 | TBI | 28 | 0 | 6/3 | 5/4 | 5/4 | 7/4 | UWS | |
| 25 | 26–30 | TBI | 23 | 0 | 6/5 | 6/5 | 7/6 | 7/5 | UWS | |
| 26 | 20–25 | TBI | 21 | 0 | 5/3 | 6/3 | 7/4 | 7/4 | UWS* | |
| 27 | 66–70 | ANOX | 25 | 0 | 5/4 | 6/4 | 6/5 | 7/7 | UWS | |
| 28 | 60–65 | ANOX | 23 | 0 | 5/1 | 5/2 | 4/2 | 4/2 | UWS | |
| 29 | 26–30 | ANOX | 31 | 0 | 3/3 | 3/3 | 6/3 | 6/3 | UWS | |
| 30 | 40–45 | ANOX | 37 | 0 | 4/1 | 5/2 | 6/2 | 5/3 | UWS | |
| 1 | HC | 50–55 | ||||||||
| 2 | 20–25 | |||||||||
| 3 | 20–25 | |||||||||
| 4 | 30–35 | |||||||||
| 5 | 36–40 | |||||||||
| 6 | 26–30 | |||||||||
| 7 | 36–40 | |||||||||
| 8 | 20–25 | |||||||||
| 9 | 36–40 | |||||||||
| 10 | 36–40 | |||||||||
| 11 | 40–45 | |||||||||
| 12 | 26–30 | |||||||||
| 13 | 40–45 | |||||||||
MCS, Minimally Conscious State; UWS, Unresponsive Wakefulness Syndrome; UWS*, patients without CR that change the level of consciousness after 6 months from the onset; HEM, Hemorrhagic; TBI, Traumatic Brain Injury; ANOX, Anoxic; CR, Conditional Response (0 = absent; 1 = present); CRS-R, Coma Recovery Scale–Revised; NCS, Nociception Coma Scale; Week (I-IV), Successive weeks during which the patients were assessed by CRS-R and NCS. In bold patients with Trace Conditioning.
Figure 1Sequence of the stimuli: two short grave notes anticipate the musical stimulus; two short grave notes and one long acute note at an interval of 5th anticipate the noxious stimulus. From Sequence (A) 1 to 7 the stimuli were associated to the tones; the eighth without stimulus administration to verify the CR; Sequence (B) from 9 to 16 only tones for the extinction of the stimulus.
Figure 2Protocol and data analysis: in the central line of the figure (between dashed lines) the entire sequence of the protocol (baseline, sequence A to test the conditional response (CR), and sequence B to test the extinction of the CR). From each sequence Galvanic Skin Response (GSR) and Electrocardiogram (ECG) were extracted. From the ECG the Inter-Beats Interval (distance between peak to peak of RR ECG signal) was extracted (Bottom the figure—HRV analysis) and Sample Entropy (SampEn) analyzed, then compared between and within groups. GSR was observed in baseline to exclude artifact movements. GRS analysis (above) was performed considering peak magnitude, time to reach the peak, and decay of the GSR signal in the last three phases of the sequence A (black box and black line MUS4, NOC3, and NOC*). It was considered the CR only if the GSR was present in NOC3 and NOC* (circle white filled). Finally, CR's (red box) extinction was observed in the sequence B. Similarly, for the SampEn, the GSR components (magnitude, time to reach the peak, and decay) were compared between and within groups (black line) and the extinction was compared for wave peak magnitude (red line).
Figure 3Phasic components of GSR in the sequence A. The bold line is the mean of the GSR signal, and the filled area is the standard error. In blue the HC, green UWS patients with CR, and red UWS patients without CR. Vertical black continuous lines are the start of nociception stimulus, dashed black lines are the start of musical stimulus, vertical red line is the start of CR. MUS4, NOC3, and NOC* were considered in the statistical analysis to verify the conditional learning.
Figure 4Characteristics of the wave in the GSR signal. After the stimulus, the time to reach the peak of max magnitude is calculated. The magnitude is different between values of peak and values at the start of the stimulus. The time of the wave's decay is the phase of decreasing after reaching the peak.
Figure 5Sequence A: boxplot of the GSR waves components. Time to reach the peak (left), wave's magnitude (center) and wave's decay (right) of each group were compared among them in MUS4, NOC3, and NOC* (diamond markers), and the groups (HC, UWS1, and UWS0) were compared among them for each session (point markers). The box represents the first and third quartile, the whiskers are the 1.5 interquartile range, the black lines are the medians, and points are outliers. Significant statistical difference: ∙p = [0.002–0.003]; ∙∙p = 0.001; ∙∙∙p < 0.0001; circle: Statistical difference between groups .
Statistic results for GSR in MUS4, NOC3, and NOC* and for SampEn in Baseline, sequence A and sequence B.
| UWS0 vs. UWS1 | ns | ns | ns | ns | ns | ns | |||
| UWS1 vs. HC | ns | ns | ns | ns | ns | ns | ns | ns | ns |
| UWS0 vs. HC | ns | ns | ns | ns | ns | ||||
| Music vs. Nociception | ns | ns | ns | ||||||
| Nociception vs. Test | ns | ns | |||||||
| Music vs. Test | ns | ns | ns | ||||||
| Baseline | ns | ns | ns | UWS0 | ns | ||||
| Trace Conditioning (Sequence A) | ns | UWS1 | ns | ns | |||||
| Extinction (Sequence B) | ns | ns | HC | ns | ns | ||||
UWS0, Unresponsive Wakefulness syndrome patients with no Conditional Response; UWS1, Unresponsive Wakefulness syndrome patients with Conditional Response.
p-value: ••• p < 0.0001, r-value: M (effect size Medium 0.3 ≤ r < 0.5).
p-value: ••p = 0.001, r-values: H (effect size High r ≥ 0.5).
p-value: 0.002 ≤ p ≤ 0.004.
Figure 6Sequence B: boxplot of GSR magnitude. MUS4 vs. MUS1* and NOC* vs. NOC1* were compared. Only in the HC and UWS1 groups a significant difference between NOC* and NOC1* was observed (***HC: Z = −3.180, p < 0.0001, r = 0.88; **UWS1: Z = −2.666; p = 0.002; r = 0.60). The box represents the first and third quartile, the whiskers are the 1.5 interquartile range, the black lines are the medians, and points are outliers.
Figure 7Boxplot of the SampEn. In the figure: baseline (white), sequence A (dark gray) and sequence B (light gray). Significant statistical difference: *p = [0.003–0.005]; **p = [0.001]; ***p < 0.0001.
Figure 8Boxplot of the CRS-R and NCS. UWS0 (dark gray) and UWS1 (white) groups are compared for CRS-R and NCS. The box represents the first and third quartile, the whiskers are the 1.5 interquartile range, the black lines are the medians, and points are outliers. The statistical difference between groups is significant at the 3rd week (CRS-R: Z = −3.512; p < 0.0001 – NCS: Z = −2.964; p = 0.001) and 4th week (CRS-R: Z = −3.566; p < 0.0001 – NCS: Z = −2.214; p = 0.015).
Results of the prognostic power the CR observed by the protocol, and results of the One-R classifier in the correct classification of the presence/absence of the CR.
| Sensitivity (%) | 100 | Sensitivity (%) | 95 | 86 | 86 | 71 | ||
| Specificity (%) | 95 | Specificity (%) | 95 | 85 | 86 | 67 | ||
| Accuracy (%) | 97 | Accuracy (%) | 91 | 86 | 84 | 72 | ||
| Precision (%) | 90 | Precision (%) | 86 | 86 | 82 | 77 | ||
| False Positive Rate (%) | 5 | False Positive Rate (%) | 13 | 14 | 18 | 26 | ||
| False Negative Rate (%) | 0 | False Negative Rate (%) | 5 | 14 | 14 | 29 | ||
| F1 score [0:1] | 0.9 | 0.86 | 0.84 | 0.74 | ||||
The best performance in bold (Peak magnitude NOC*). Additionally, the results with the parameters Peak magnitude NOC3 and SampEn.